AXSM - Axsome Therapeutics Inc (Healthcare: Biotechnology) Projected Earnings Date: 2024-08-09    (Delayed quote data   2025-07-11)
Last
 108.98		 Change
 ⇓ -1.75   (-1.58%)		 Volume
  978,142
Open
 109.67		 High
 112.21		 Low
 108.48
8EMA (Daily)
 108.13		 40EMA (Daily)
 106.65		 50EMA (Daily)
 106.92		 STO (Daily)
 78.870		 MACD Hist (Daily)
 1.783
8EMA (Weekly)
 106.186		 40EMA (Weekly)
 102.92		 50EMA (Weekly)
 100.70		 STO (Weekly)
 46.339		 MACD Hist (Weekly)
 -1.701
Company Profile
Axsome Therapeutics Inc is a clinical-stage biopharmaceutical company. It is engaged in developing novel therapies for the management of the central nervous system, or CNS, disorders for which there are limited treatment options. Its pipeline products include AXS-05, AXS-07, AXS-12, and others.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com